Biotechnology
New patent for Guerbet drug ELUCIREM – DrugPatentWatch
Copyright © DrugPatentWatch. Originally published in New patent for the Guerbet drug ELUCIREM
Annual Drug Patent Expiration for ELUCIREM
Elucirem is a drug marketed by Guerbet and included in one NDA. It is available from two suppliers. There are two patents protecting this drug.
This drug has thirty-six patent family members in thirteen countries.
The generic ingredient in ELUCIREM is gadopiclenol. Two registered suppliers for this compound. Additional details are available on the gadopiclenol profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patent for the Guerbet drug ELUCIREM
